543595 — EP Biocomposites Balance Sheet
0.000.00%
- IN₹211.87m
- IN₹225.48m
- IN₹120.06m
- 46
- 47
- 15
- 26
Annual balance sheet for EP Biocomposites, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.48 | 1.56 | 21.9 | 12.7 | 16.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.68 | 71.4 | 60.1 | 99.6 | 110 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 13 | 85.8 | 92.6 | 125 | 141 |
Net Property, Plant And Equipment | 0.024 | 2.37 | 2.02 | 3.78 | 3.19 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 13.2 | 92.8 | 117 | 151 | 166 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9.37 | 50.8 | 20.8 | 44 | 35.8 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 9.37 | 72.8 | 33.1 | 55.1 | 60.3 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.87 | 20 | 84.1 | 95.6 | 106 |
Total Liabilities & Shareholders' Equity | 13.2 | 92.8 | 117 | 151 | 166 |
Total Common Shares Outstanding |